Hikma Pharmaceutical | HIK - Loan Capital


Hikma Pharmaceutical reported $1.49B in Loan Capital for its fiscal semester ending in December of 2025.





Loan Capital Change Date
Almirall EUR 324.81M 61.32M Dec/2025
argenx SE USD 35.57M 3.05M Jun/2025
AstraZeneca USD 25.96B 177M Mar/2026
Autolus Therapeutics Ltd USD 277.27M 7.07M Mar/2026
Bayer EUR 30.68B 1.15B Mar/2026
Fresenius EUR 9.22B 1.58B Dec/2025
Genmab DKK 5.14B 5.01B Dec/2025
GlaxoSmithKline GBP 14.01B 696M Mar/2026
GRIFOLS EUR 9.08B 612M Mar/2026
Hikma Pharmaceutical USD 1.49B 692M Dec/2025
Lakefront Biotherapeutics EUR 4.85M 335K Mar/2026
Lonza CHF 3.88B 323M Dec/2025
Merck EUR 10.8B 72M Mar/2026
Orion EUR 110.6M 4.7M Mar/2026
Recordati EUR 1.76B 373.2M Mar/2026
Roche Holding CHF 27.43B 966M Dec/2025
Sanofi EUR 13.84B 1.88B Mar/2026
UCB EUR 2.18B 634M Dec/2025